RoB 2: a revised tool for assessing risk of bias in randomised trials

Jonathan A C Sterne,Jelena Savović,Matthew J Page,Roy G Elbers,Natalie S Blencowe,Isabelle Boutron,Christopher J Cates,Hung-Yuan Cheng,Mark S Corbett,Sandra M Eldridge,Jonathan R Emberson,Miguel A Hernán,Sally Hopewell,Asbjørn Hróbjartsson,Daniela R Junqueira,Peter Jüni,Jamie J Kirkham,Toby Lasserson,Tianjing Li,Alexandra McAleenan,Barnaby C Reeves,Sasha Shepperd,Ian Shrier,Lesley A Stewart,Kate Tilling,Ian R White,Penny F Whiting,Julian P T Higgins
DOI: https://doi.org/10.1136/bmj.l4898
2019-08-28
BMJ
Abstract:Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We updated the tool to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.
What problem does this paper attempt to address?